Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Core Scientific (CORZZ) EBT Margin (2021 - 2025)

Historic EBT Margin for Core Scientific (CORZZ) over the last 5 years, with Q3 2025 value amounting to 180.68%.

  • Core Scientific's EBT Margin rose 2966200.0% to 180.68% in Q3 2025 from the same period last year, while for Sep 2025 it was 229.65%, marking a year-over-year decrease of 65200.0%. This contributed to the annual value of 257.34% for FY2024, which is 2084100.0% down from last year.
  • As of Q3 2025, Core Scientific's EBT Margin stood at 180.68%, which was up 2966200.0% from 1191.23% recorded in Q2 2025.
  • In the past 5 years, Core Scientific's EBT Margin registered a high of 730.46% during Q1 2025, and its lowest value of 1191.23% during Q2 2025.
  • Over the past 5 years, Core Scientific's median EBT Margin value was 137.64% (recorded in 2023), while the average stood at 178.7%.
  • Data for Core Scientific's EBT Margin shows a peak YoY increase of 6128300bps (in 2025) and a maximum YoY decrease of -6209000bps (in 2025) over the last 5 years.
  • Over the past 5 years, Core Scientific's EBT Margin (Quarter) stood at 25.5% in 2021, then plummeted by -1576bps to 376.36% in 2022, then surged by 63bps to 137.64% in 2023, then crashed by -103bps to 279.34% in 2024, then skyrocketed by 35bps to 180.68% in 2025.
  • Its last three reported values are 180.68% in Q3 2025, 1191.23% for Q2 2025, and 730.46% during Q1 2025.